There is no commonly accepted grading scheme for phyllodes tumors of the breast, which can range from relatively benign to aggressive tumors. Lester gives one method for grading these tumors.
Parameters:
(1) cellularity
(2) nuclear pleomorphism
(3) mitotic rate in 10 high power microscopic fields (HPF, using 40x objective)
(4) stromal overgrowth (areas with abundant stroma and no epithelial cells)
(5) borders/margins of the tumor
(6) heterologous elements
Histologic Feature |
Low Grade |
Intermediate ("Borderline") |
High Grade |
stromal cellularity |
mild |
moderate |
marked |
nuclear pleomorphism |
minimal |
moderate |
marked |
mitotic rate |
present but low (0 to 1 in 10 HPF) |
2 to 10 in 10 HPF |
> 10 in 10 HPF |
stromal overgrowth |
absent or focal |
often present |
may be marked |
borders |
pushing, well-circumscribed |
some infiltration |
marked invasion |
heterologous elements |
benign, usually bone or fat |
benign, usually bone or fat |
malignant stromal elements |
where:
• The data given by Lester used mitotic rate of 2-5 for intermediate and >= 6 for high grade. I have used the WHO criteria in the table above..
Limitations:
• Low grade tumors have been known to metastasize.
• High grade tumors have been cured by simple excision.
Specialty: Hematology Oncology, Surgery, general, Obstetrics & Gynecology
ICD-10: ,